Pham, L.V.; Velázquez-Moctezuma, R.; Fahnøe, U.; Collignon, L.; Bajpai, P.; Sølund, C.; Weis, N.; Holmbeck, K.; Prentoe, J.; Bukh, J.
Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization. Viruses 2022, 14, 2527.
https://doi.org/10.3390/v14112527
AMA Style
Pham LV, Velázquez-Moctezuma R, Fahnøe U, Collignon L, Bajpai P, Sølund C, Weis N, Holmbeck K, Prentoe J, Bukh J.
Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization. Viruses. 2022; 14(11):2527.
https://doi.org/10.3390/v14112527
Chicago/Turabian Style
Pham, Long V., Rodrigo Velázquez-Moctezuma, Ulrik Fahnøe, Laura Collignon, Priyanka Bajpai, Christina Sølund, Nina Weis, Kenn Holmbeck, Jannick Prentoe, and Jens Bukh.
2022. "Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization" Viruses 14, no. 11: 2527.
https://doi.org/10.3390/v14112527
APA Style
Pham, L. V., Velázquez-Moctezuma, R., Fahnøe, U., Collignon, L., Bajpai, P., Sølund, C., Weis, N., Holmbeck, K., Prentoe, J., & Bukh, J.
(2022). Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization. Viruses, 14(11), 2527.
https://doi.org/10.3390/v14112527